Page 658 - Read Online
P. 658

Page 10 of 14                            Tafur et al. J Cancer Metastasis Treat 2018;5:xx  I  http://dx.doi.org/10.20517/2394-4722.2018.102

                                  A            MCT1                    PR








                                   siNT   +   +    _    _   siNT   +   +    _   _
                                   siGPR81  _  _   +   +   siGPR81  _  _    +   +
                                   Tamoxifen  _  +  _  +   Tamoxifen  _  +  _   +
                                   B           Ki67                    CyclinB1









                                   siNT   +    +   _    _   siNT   +   +    _    _
                                   siGPR81  _  _   +    +   siGPR81  _  _   +   +
                                   Tamoxifen  _  +  _   +   Tamoxifen  _  +  _  +
                                   C                        D        Cleaved PARP








                                   siNT   +    +    _   _   siNT   +   +    _    _
                                   siGPR81  _  _   +    +   siGPR81  _  _   +   +
                                   Tamoxifen  _  +  _   +   Tamoxifen  _  +  _   +
                                                          cleaved PARP
                                                              β-actin
               Figure 6. Additive effect of GPR81 knockdown and Tamoxifen treatment in reducing the cell proliferation and increasing cell apoptosis
               in epithelial MCF-7 breast cancer cells. MCF-7-siNT (control) and MCF-7-siGPR81 cancer cells were treated with or without 1 μmol/L
               Tamoxifen for 96 h in 3-dimensional Matrigel with physiological modified medium. A: real-time qPCR analysis of lactate importer MCT1;
               and progesterone receptor PR; B: relative mRNA expression of proliferation markers: Ki67 and Cyclin B1; C: viable cell counts of epithelial
               MCF-7-siNT and MCF-7-siGPR81; D: Western blot analysis of cell lysates from MCF-7-siNT and MCF-7-siGPR81 used to detect protein
               expression levels of the apoptotic maker cleaved-PARP. β-actin was used as a loading control. Results are presented as mean ± S.E.M. of
               three independent experiments *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 (ordinary one-way ANOVA)

               conditions [Figure 5D]. Similarly, we found that treatment with the MCT1 inhibitor also prevented cell
               growth when in MCF-7 cells were culture in nutrient-limited conditions [Figure 5E]. Taken together, these
               data support the physiological role for GPR81 in the regulation of lactate uptake, cell proliferation and
               survival of the epithelial MCF-7 breast cancer cells under nutrient-limited conditions.

               Tamoxifen treatment in reducing cell proliferation and increasing cell apoptosis has additive
               effect on GPR81 knockdown
               We observed here that 1 µmol/L Tamoxifen further reduced MCT1 gene expression in GPR81-silenced MCF-
               7 cells treated for 4 days [Figure 6A]. The effect of Tamoxifen was confirmed by the reduced expression
               of the progesterone receptor . We next evaluated the effects of Tamoxifen and GPR81 silencing in cell
                                        [35]
               proliferation and apoptosis in ER+ MCF-7 breast cancer cells. GPR81 knockdown and Tamoxifen treatment
               had an additive effect on the reduction of cell proliferation markers; Ki67 and Cyclin B1 [Figure 6B], as
               well as viable cell numbers of MCF-7 cells in MPM culture [Figure 6C]. Additionally, cell apoptosis was
               significantly increased only in MCF-7-siGPR81 cells independently of Tamoxifen treatment, showed by the
               increased expression of the apoptotic marker cleaved PARP [Figure 6E]. These data suggest GPR81 regulates
               cell proliferation and apoptosis.
   653   654   655   656   657   658   659   660   661   662   663